Procalcitonin in advanced urological cancer-bacterial versus non-bacterial infections: prospective cohort study.

Hiroshi YaegashiKouji IzumiRen ToriumiShuhei AoyamaTaiki KamijimaHiroshi KanoTomoyuki MakinoRenato NaitoHiroaki IwamotoShohei KawaguchiTakahiro NoharaKazuyoshi ShigeharaAtsushi Mizokami

Published in: BMJ supportive & palliative care (2024)

Procalcitonin is a rapid and affordable marker for differentiation between BI and NBI in patients with advanced urological cancer.

Keyphrases

papillary thyroid
squamous cell
lymph node metastasis
quantum dots
sensitive detection